T
Tusker Medical
Company focused on delivering innovative technology to Ear, Nose, and Throat surgeons and their patients
About Tusker Medical
Tusker Medical, established in 2016 and headquartered in Menlo Park, California, operated as a medical device company focused on pediatric ear, nose, and throat (ENT) solutions. The company was founded by a team that included seasoned medical device executive Amir Abolfathi, who served as President and CEO. Abolfathi brought extensive experience from previous roles at companies like Align Technology, Sonitus Medical, and EndoTex Interventional Systems, demonstrating a career focused on developing and commercializing novel medical technologies. Tusker Medical's formation has roots in Johnson & Johnson, which spun the underlying technology out to the life sciences fund Apple Tree Partners, a key investor who then established the company.
The firm's core business centered on addressing recurrent or persistent ear infections (otitis media), a common ailment in children that often requires surgery to place tympanostomy tubes. Tusker Medical developed the Tula System, a groundbreaking product designed to enable the placement of these ear tubes in a physician's office, thereby avoiding the need for general anesthesia in a hospital setting. This addressed a significant unmet clinical need by reducing the risks, stress, and costs associated with general anesthesia for young patients and their caregivers. The company's clients were primarily ENT surgeons, both general and pediatric.
The Tula System is a comprehensive, multi-part device. It includes the Tula Iontophoresis System, which uses a small electrical current to deliver a proprietary local anesthetic drug, TYMBION™, directly to the eardrum in a needle-free manner. Once the area is numb, the second component, the Tula Tube Delivery System, is used to automatically create an incision (myringotomy) and insert the ear tube with a single button press. This procedure can be performed on patients as young as six months old. A significant milestone was achieved in November 2019 when the Tula System received both FDA Breakthrough Device designation and pre-market approval (PMA). Shortly after this regulatory success, in January 2020, the global medical technology company Smith & Nephew acquired Tusker Medical, integrating the Tula System into its existing ENT portfolio.
Source: Dealroom company dataNews
Open roles
Tusker Medical in the Menlo Park ecosystem
The Tusker Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tusker Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tusker Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

